CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,332,730 | -10.2% | 114,006 | +3.2% | 0.03% | -12.5% |
| Q2 2023 | $1,484,771 | -35.8% | 110,474 | -20.8% | 0.03% | -42.9% |
| Q1 2023 | $2,312,098 | +552.7% | 139,451 | +632.2% | 0.06% | +460.0% |
| Q4 2022 | $354,237 | -45.0% | 19,045 | -62.0% | 0.01% | -47.4% |
| Q3 2022 | $644,000 | +563.9% | 50,175 | +53.7% | 0.02% | +533.3% |
| Q3 2020 | $97,000 | -70.0% | 32,653 | -53.3% | 0.00% | -70.0% |
| Q2 2020 | $323,000 | -33.9% | 69,872 | -45.0% | 0.01% | -28.6% |
| Q1 2020 | $489,000 | +256.9% | 126,934 | +247.6% | 0.01% | +366.7% |
| Q4 2019 | $137,000 | -35.1% | 36,514 | -8.3% | 0.00% | -25.0% |
| Q3 2019 | $211,000 | – | 39,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |